2017-03-14,AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results
2017-03-13,Tesaro Announces Presentation Of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results During SGO
2017-03-12,TESARO Announces Niraparib Data Presentations At The 2017 SGO Annual Meeting On Women's Cancer
2017-03-10,Incyte Pops on Continued Gilead Takeout Speculation
2017-03-01,Invest Like a Venture Capitalist With These 4 Stocks
2017-03-01,Forget the Snapchat IPO--Invest Like a Venture Capitalist With These 4 Stocks
2017-02-28,TESARO Announces Fourth-Quarter 2016 Operating Results
2017-02-27,TESARO Receives Positive CHMP Opinion For VARUBY®
2017-02-21,TESARO Announces Participation At Two Investor Conferences
2017-02-20,Your Burning Biotech Questions Answered
2017-02-17,Clovis, Tesaro Soar on Astrazeneca Phase Three News
2017-02-17,Your Burning Biotech Questions Answered
2017-02-15,Biotech Buoyed by Deal Talk
2017-02-14,Tesaro To Announce Fourth-Quarter 2016 Financial Results On February 28, 2017
2017-02-13,Morgan Stanley, Twitter, Tesaro: Doug Kass' Views
2017-02-10,Analysts' Actions -- Ford, Intel, Twitter, Viacom and More
2017-02-08,Notable Wednesday Option Activity: TSRO, PRLB, SPSC
2017-02-08,Biotech Tesaro Climbs on Takeout Reports
2017-02-02,Tesaro Announces Participation At Two Investor Conferences
2017-01-17,Tesaro Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer
2017-01-12,These 3 Biotech Stocks Are Already Moving Wildly on Thursday
2017-01-11,TESARO Receives Complete Response Letter For Rolapitant IV From U.S. FDA
2017-01-05,3 Biotechs Screaming 'Takeover Target'
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-20,Tesaro Announces Priority Review Designation For Niraparib NDA
2016-11-30,Analysts' Actions -- Goldman Sachs, Celanese, SBA Communications and More
2016-11-29,Ratings Changes Today
2016-11-21,Tesaro Announces Participation In Three Investor Conferences
2016-11-17,Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!
2016-11-15,TESARO Announces Pricing Of Public Offering Of Common Stock
2016-11-14,TESARO Announces Proposed Public Offering Of Common Stock
2016-11-03,TESARO Announces Third-Quarter 2016 Operating Results
2016-11-01,Tesaro Announces Submission Of Niraparib New Drug Application For Platinum-Sensitive, Recurrent Ovarian Cancer
2016-10-31,TESARO Announces Presentation Of Niraparib Data At The 2016 IGCS Biennial Meeting
2016-10-27,TESARO Announces Acceptance For Review Of Niraparib Marketing Authorization Application By EMA
2016-10-26,AstraZeneca Is Now a Competitive Threat to Tesaro in Ovarian Cancer Maintenance Therapy
2016-10-24,TESARO Announces Participation In Three Investor Conferences
2016-10-20,Tesaro To Announce Third-Quarter 2016 Financial Results On November 3, 2016
2016-10-10,Closing Bell: Stocks Lifted by Oil Prices; Facebook Launches Work-Friendly Social Network
2016-10-10,Stocks Buoyed by Higher Oil Prices; Investors Await Third-Quarter Earnings
2016-10-10,Stocks Maintain Gains as Oil Rallies
2016-10-10,Trending Tickers: MRK, BMY, TSRO, TWLO, CRM
2016-10-10,Even High-Flying Tesaro and Its Ovarian Cancer Drug Has a Bear Thesis. Here It Is, Explained
2016-10-10,Tesaro (TSRO) Stock Soars on Ovarian Cancer Trial Success, Upgraded
2016-10-10,Rev's Forum: News Flow Works Against the Bears Once More
2016-10-10,Analysts' Actions -- American Eagle, Mattel, Netflix, Tesaro and More
2016-10-08,Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows
2016-10-08,TESARO And ENGOT Announce Presentation Of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016
2016-10-04,Investor's Guide to This Week's Clovis, Tesaro Ovarian Cancer Drug Updates
2016-09-29,TESARO And Zai Lab Announce Collaboration, Development And License Agreement
2016-09-21,Is Tesaro Another M&amp;A Target? The Charts Say It Is
2016-09-12,TESARO Receives FDA Fast Track Designation For Niraparib And Initiates Rolling NDA Submission
2016-09-06,Is Bad News Necessarily a Bad Thing?
2016-09-06,TESARO Announces Six Data Presentations At The 2016 European Society For Medical Oncology (ESMO) Annual Meeting
2016-08-24,TESARO Announces Participation At Four Investor Conferences
2016-08-23,Healthy Market Action Takes an Unhealthy Turn
2016-08-22,Here's a Reason Why Tesaro (TSRO) Stock Climbed Today
2016-08-22,Medivation Scores Premium in Sale to Pfizer
2016-08-22,Facebook Stands Out and FormFactor Has a Good Start
2016-08-22,Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation
2016-08-17,Nice Recovery, But Momentum Is Missing
2016-08-09,It May Be Dull, but That's No Reason to Be Negative
2016-08-04,Tesaro Announces Second-Quarter 2016 Operating Results
2016-07-27,In the Red, and Breadth Is Steadily Slipping
2016-07-21,TESARO To Announce Second-Quarter 2016 Financial Results On August 4, 2016
2016-07-20,Market Momentum Is on the Move
2016-07-14,'Mad Money' Lightning Round: I'm Not Turning My Back on Blackstone
2016-07-13,Jim Cramer's 'Mad Money' Recap: Is the Bull Resting or Out the Gate?
2016-07-12,I Am Watching Some Momentum Names
2016-07-08,ENGOT And TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial
2016-07-07,TESARO Announces Closing Of Public Offering Of Common Stock And Exercise Of Option By Underwriters
2016-07-07,Price Patterns Never Lie
2016-07-06,The Market Mood Is Sour
2016-07-05,Summer Trading at Its Finest
2016-06-30,TESARO Announces Pricing Of Public Offering Of Common Stock
2016-06-30,5 Hot Stocks to Watch Right Now
2016-06-30,Protect Gains Into the Holiday Weekend
2016-06-30,Dr. Marc Siegel Explains Why Tesaro (TSRO) Cancer Drug Is a Big Deal
2016-06-30,Tesaro (TSRO) Stock Slumps on Public Offering, Leerink Lifts Price Target
2016-06-30,Analysts' Actions -- General Mills, Priceline, Pulte, Yelp and More
2016-06-30,TESARO Announces Proposed Public Offering Of Common Stock
2016-06-29,What Tesaro's Cancer Drug Success Means for Medivation
2016-06-29,Tesaro (TSRO) Stock Skyrockets on Success of Ovarian Cancer Drug
2016-06-29,2 Big-Volume Stocks to Add to Your Buy List -- Plus 5 Risky Ones to Avoid
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-29,TESARO's Niraparib Significantly Improved Progression-Free Survival For Patients With Ovarian Cancer In Both Cohorts Of The Phase 3 NOVA Trial
2016-06-23,TESARO Announces Rolapitant Data Presentations At The 2016 MASCC/ISOO Annual Meeting On Supportive Care In Cancer
2016-06-04,TESARO Provides Pipeline Update At ASCO Investor Briefing
2016-05-21,5 Stocks to Sell in May Before They Destroy Your Portfolio
2016-05-18,TESARO Announces Five Abstracts To Be Presented At The 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting
2016-05-05,TESARO Announces First-Quarter 2016 Operating Results
2016-04-25,TESARO Announces Submission Of Investigational New Drug Application For Anti-TIM-3 Antibody TSR-022 To The U.S. FDA
2016-04-22,5 Toxic Stocks You Should Sell Now
2016-04-21,TESARO To Announce First Quarter 2016 Financial Results On May 5, 2016
2016-04-06,TESARO Announces Global Prostate Cancer Collaboration And Licensing Agreement With Janssen
2016-04-04,TESARO Announces Appointment Of Dr. Kavita Patel To Board Of Directors
2016-03-29,TESARO Announces Enrollment Of First Patient In Phase 1 Clinical Trial Of TSR-042
2016-03-29,TESARO And MD Anderson Cancer Center Announce Immuno-Oncology Collaboration And Exclusive License Agreement
2016-03-23,TESARO Announces Validation Of Marketing Authorisation Application For Oral Rolapitant By The European Medicines Agency
2016-03-21,Ally Bridge Group (ABG) Completes Its Investment In TESARO, Inc. (TSRO)
2016-03-18,TESARO Announces Closing Of $155 Million Private Placement
2016-03-14,TESARO Submits New Drug Application For Intravenous Rolapitant To The U.S. Food And Drug Administration
2016-02-25,TESARO Announces Fourth-Quarter 2015 Operating Results
2016-02-25,TESARO Announces Definitive Agreement For $155 Million Private Placement
2016-02-11,Tesaro To Announce Fourth Quarter 2015 Financial Results On February 25, 2016
2016-02-03,TESARO To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-11,TESARO Outlines Business Priorities And Strategic Outlook For 2016
2015-12-14,TESARO Added To The NASDAQ Biotechnology Index
2015-11-16,TESARO Announces The Launch Of VARUBI(TM) (Rolapitant) In The United States
2015-11-16,TESARO Announces The Launch Of VARUBI™ (rolapitant) In The United States
2015-11-06,TESARO Announces Data Presentations For Niraparib At The 2015 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
2015-10-29,TESARO Announces Third-Quarter 2015 Operating Results
2015-10-22,TESARO Announces Participation In Three Investor Conferences
2015-10-15,TESARO To Announce Third-Quarter Financial Results On October 29, 2015
2015-09-25,First Week of TSRO November 20th Options Trading
2015-09-24,TESARO Announces Inclusion Of VARUBI(TM) (rolapitant) In NCCN(R) Antiemesis Guidelines
2015-09-21,TESARO Appoints Martin Huber, M.D., As Senior Vice President And Chief Medical Officer
2015-09-03,First Week of TSRO October 16th Options Trading
2015-09-02,TESARO Announces U.S. FDA Approval Of VARUBI(TM) (rolapitant) For Nausea And Vomiting Associated With Cancer Chemotherapy
2015-09-01,TESARO Announces Participation At Three Investor Conferences
2015-08-06,TESARO Announces Second-Quarter 2015 Operating Results
2015-07-30,Tesaro And Jiangsu Hengrui Medicine Announce Rolapitant License Agreement For China
2015-07-23,TESARO To Announce Second-Quarter Financial Results On August 6, 2015
2015-07-13,TESARO Appoints Grant C. Bogle As Senior Vice President And Chief Commercial Officer
2015-06-29,TESARO Appoints Jeffrey H. Hanke, Ph.D., As Executive Vice President, Research & Development, And Chief Scientific Officer
2015-06-25,TESARO Announces Six Abstracts To Be Presented At The 2015 Multinational Association Of Supportive Care In Cancer Annual Meeting
2015-05-30,TESARO Announces Successful Completion Of Rolapitant Bioequivalence Study
2015-05-30,TESARO And Merck To Collaborate On A Combination Study Of Niraparib And KEYTRUDA(R) (Pembrolizumab)
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-20,TESARO Announces Webcast Of Presentation At The Jefferies 2015 Global Healthcare Conference
2015-05-14,TESARO Announces Election Of Garry A. Nicholson To Board Of Directors And Results Of Annual Stockholder Meeting
2015-05-13,TESARO Announces Seven Abstracts To Be Presented At The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-04-30,TESARO Announces Completion Of Targeted Enrollment In Phase 3 NOVA Trial And Initiation Of The QUADRA Trial Of Niraparib
2015-04-30,TESARO Announces First-Quarter 2015 Operating Results
2015-04-23,TESARO Launches Campaign To Raise Awareness Of Chemotherapy-Induced Nausea And Vomiting Among Patients With Cancer
2015-04-22,TESARO Announces Participation At Three Investor Conferences
2015-04-16,TESARO To Announce First-Quarter Financial Results On April 30, 2015
2015-04-14,TESARO Announces Upcoming Immuno-Oncology Presentations
2015-04-09,TESARO Announces Nomination Of Garry A. Nicholson For Election To Board Of Directors
2015-03-31,TESARO Appoints Joseph Farmer, As Senior Vice President, General Counsel And Secretary
2015-03-17,TSRO: Insiders Vs. Shorts
2015-03-09,TESARO Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option By Underwriters
2015-03-05,TESARO To Present At The Barclays Global Healthcare Conference
2015-03-03,TESARO Announces Pricing Of Public Offering Of Common Stock
2015-03-02,TESARO Announces Proposed Public Offering Of Common Stock
2015-02-26,18.5% Of XBI Holdings Seeing Recent Insider Buys
2015-02-19,TESARO Announces Fourth-Quarter 2014 Operating Results
2015-02-05,TESARO To Announce Fourth-Quarter 2014 Financial Results On February 19, 2015
2015-02-05,TESARO To Present At The Leerink Global Healthcare Conference
2015-01-12,CORRECTING And REPLACING -- TESARO Announces Expansion Of Niraparib Clinical Program And Outlines Late-Stage Program Milestones For 2015
2015-01-12,TESARO Announces Expansion Of Niraparib Clinical Program And Outlines Late-Stage Program Milestones For 2015
2014-12-16,TSRO: Insiders Vs. Shorts
2014-12-02,TESARO And AnaptysBio Expand Immuno-Oncology Collaboration To Include Novel Bispecific Antibody Candidate
2014-11-25,TESARO To Present At The 2014 Deutsche Bank BioFEST
2014-11-25,TESARO To Present At The Nasdaq 31st Investor Program
2014-11-15,'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
2014-11-12,TESARO To Present At The Jefferies 2014 Global Healthcare Conference
2014-11-05,TESARO Announces Third-Quarter 2014 Operating Results
2014-10-27,Short Interest Jumps 17.3% For TSRO
2014-10-22,Tesaro To Announce Third-Quarter 2014 Financial Results On November 5, 2014
2014-09-29,TESARO Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes
2014-09-23,TESARO Announces Pricing Of $175 Million Of 3.00% Convertible Senior Notes Due 2021
2014-09-22,TESARO Announces Offering Of $165 Million Of Convertible Senior Notes Due 2021
2014-09-08,OPKO Licensee TESARO Submits New Drug Application For Rolapitant
2014-09-08,TESARO Announces Submission Of Rolapitant New Drug Application (NDA) To U.S. Food And Drug Administration
2014-08-25,Tesaro (TSRO) Shares Cross Above 200 DMA
2014-08-21,TESARO Announces Participation At Several Upcoming Investor Conferences
2014-07-24,TESARO Announces Second-Quarter 2014 Operating Results
2014-07-24,TESARO Appoints Mary Lynne Hedley, Ph.D., As Chief Operating Officer
2014-07-10,TESARO To Announce Second-Quarter 2014 Financial Results On July 24, 2014
2014-07-09,3 Big Stocks on Traders' Radars
2014-07-09,'Fast Money' Recap: Waiting for the Dust to Settle
2014-06-27,TESARO Summarizes Rolapitant Data Presented At The 2014 MASCC/ISOO International Symposium On Supportive Care In Cancer
2014-06-25,Short Interest In Tesaro Increases 13.7%
2014-06-01,Tesaro Summarizes Phase 3 Rolapitant Data Presented At The 2014 American Society Of Clinical Oncology (ASCO) Annual Meeting And Provides An Update On Niraparib Development Strategy
2014-05-27,TESARO Appoints Tim Pearson As Chief Financial Officer
2014-05-27,TESARO Announces Webcast Of Investor & Analyst Briefing At ASCO
2014-05-16,TESARO Announces Election Of Earl M. (Duke) Collier, Jr. To Board Of Directors And Results Of Annual Stockholder Meeting
2014-05-14,TESARO Announces Six Abstracts To Be Presented At The 2014 American Society Of Clinical Oncology (ASCO) Annual Meeting
2014-05-14,TESARO To Present At The UBS 2014 Global Healthcare Conference
